Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ABEONA THERAPEUTICS INC. (ABEO) Profit Margins

Over the twelve months to 2026-06-30, ABEONA THERAPEUTICS INC. (ABEO) had operating margin -327.6%, net margin -246.4%, free cash flow margin -319.5%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABEOABEONA THERAPEUTICS INC.Follow ABEO — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
251.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
16 Nov, in 23 days
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin92.0%93.9%93.9%100.0%————————73.7%—
Operating margin-428.3%-98.0%-186.3%-338.5%-1783.3%-2686.3%-3325.7%-1940.2%-814.2%-2994.5%-3600.8%-1346.7%-1536.9%-327.6%
Net margin-137.7%-239.1%217.9%-2894.9%-1396.7%-2460.4%-3263.9%-1890.3%-842.3%-2831.2%-2807.4%-1548.2%1223.1%-246.4%
FCF margin-415.9%-90.1%-0.0%-174.2%-1031.8%-1522.3%-2809.4%-1612.9%-363.6%-2327.2%-3084.4%-1066.9%-1448.5%-319.5%

USD millions · SEC XBRL

ABEONA THERAPEUTICS INC. — questions

What is ABEONA THERAPEUTICS INC.'s operating margin?
-327.6% over the twelve months to 2026-06-30.
What is ABEONA THERAPEUTICS INC.'s net profit margin?
-246.4% over the twelve months to 2026-06-30.

Every figure on this page comes from ABEONA THERAPEUTICS INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.